Akinyemi Oni-Orisan, PharmD, PhD

Title(s)Assistant Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address513 Parnassus Avenue
San Francisco CA 94143
Phone415-502-7551
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Michigan, Ann ArborBS12/2006Biology
    University of Michigan, Ann ArborPharmD05/2010Pharmacy
    University of North Carolina, Chapel HillPhD08/2015Pharmacotherapy and Experimental Therapeutics
    University of California, San FranciscoFellowship09/2017Clinical Pharmacology

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Characterization of response to lipid-modifying regimens for atherosclerotic cardiovascular disease using electronic health records
    NIH K01HL143109Jul 15, 2018 - Jun 30, 2023
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Torsade de pointes: A nested case-control study in an integrated healthcare delivery system. Ann Noninvasive Electrocardiol. 2021 Sep 21; e12888. Mantri N, Lu M, Zaroff JG, Risch N, Hoffmann T, Oni-Orisan A, Lee C, Iribarren C. PMID: 34547155.
      View in: PubMed   Mentions:    Fields:    
    2. MP28-03 PERCEPTIONS OF OLDER MEN USING A MOBILE HEALTH APPLICATION TO MONITOR LOWER URINARY TRACT SYMPTOMS AND TAMSULOSIN ADVERSE EFFECTS: MIXED-METHODS STUDY. Investigative Urology. 2021 Sep 1; 206(Supplement 3). Wang WE, Breyer BB, Lee LA, Rios RN, Oni-Orisan OA, Steinman SM, Sim SI, Kenfield KS, Bauer BS. .
      View in: Publisher Site   Mentions:
    3. Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network. Clin Pharmacol Ther. 2021 09; 110(3):559-562. Giacomini KM, Karnes JH, Crews KR, Monte AA, Murphy WA, Oni-Orisan A, Ramsey LB, Yang JJ, Whirl-Carrillo M. PMID: 34318925.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin. Clin Pharmacol Ther. 2021 09; 110(3):733-740. Lu B, Sun L, Seraydarian M, Hoffmann TJ, Medina MW, Risch N, Iribarren C, Krauss RM, Oni-Orisan A. PMID: 34114646.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Perceptions of older men using a mobile health application to monitor lower urinary tract symptoms and tamsulosin side effects: mixed-methods study (Preprint). JMIR Human Factors. 2021 May 28. Wang WE, Breyer BB, Lee LA, Rios RN, Oni-Orisan OA, Steinman SM, Sim SI, Kenfield KS, Bauer BS. .
      View in: Publisher Site   Mentions:
    6. Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing. Clin Transl Sci. 2021 05; 14(3):784-790. Oni-Orisan A, Srinivas N, Mehta K, Das JL, Nguyen TT, Tison GH, Bauer SR, Burian M, Funk RS, Graham RA, Biomarkers and Translational Tools Community Working Group of the American Society for Clinical Phar . PMID: 33421282.
      View in: PubMed   Mentions:    Fields:    
    7. Embracing Genetic Diversity to Improve Black Health. N Engl J Med. 2021 Mar 25; 384(12):1163-1167. Oni-Orisan A, Mavura Y, Banda Y, Thornton TA, Sebro R. PMID: 33567186.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. PERSONAL: Feasibility Study Protocol for Placebo-Controlled, Randomized n-of-1 Trials of Tamsulosin for Lower Urinary Tract Symptoms. Frontiers in Digital Health. 2020 Jun 26; 2:7. Bauer BS, Breyer BB, Oni-Orisan OA, Steinman SM, Sim SI, McCulloch MC, Kenfield KS. .
      View in: Publisher Site   Mentions:
    9. The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change. NPJ Genom Med. 2020; 5:1. Oni-Orisan A, Haldar T, Ranatunga DK, Medina MW, Schaefer C, Krauss RM, Iribarren C, Risch N, Hoffmann TJ. PMID: 31969989.
      View in: PubMed   Mentions:
    10. Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system. Pharmacogenet Genomics. 2019 10; 29(8):192-199. Fohner AE, Ranatunga DK, Thai KK, Lawson BL, Risch N, Oni-Orisan A, Jelalian AT, Rettie AE, Liu VX, Schaefer CA. PMID: 31461080.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort. Circ Genom Precis Med. 2018 09; 11(9):e002043. Oni-Orisan A, Hoffmann TJ, Ranatunga D, Medina MW, Jorgenson E, Schaefer C, Krauss RM, Iribarren C, Risch N. PMID: 30354326.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome. Prostaglandins Other Lipid Mediat. 2018 09; 138:15-22. Oni-Orisan A, Cresci S, Jones PG, Theken KN, Spertus JA, Lee CR. PMID: 30096423.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients. Pharmacogenomics. 2018 06 01; 19(9):771-782. Dong OM, Li A, Suzuki O, Oni-Orisan A, Gonzalez R, Stouffer GA, Lee CR, Wiltshire T. PMID: 29793377.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Validation of Electronic Health Records for the Assessment of Statin Dosing In Research. Journal of Clinical Lipidology. 2017 May 1; 11(3):836-837. Oni-Orisan OA, Hoffmann HT, Medina MM, Jorgenson JE, Schaefer SC, Krauss KR, Iribarren IC, Risch RN. .
      View in: Publisher Site   Mentions:
    15. Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. J Clin Invest. 2017 Feb 01; 127(2):670-680. Bai X, Mangum KD, Dee RA, Stouffer GA, Lee CR, Oni-Orisan A, Patterson C, Schisler JC, Viera AJ, Taylor JM, Mack CP. PMID: 28112683.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    16. Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study. J Lipid Res. 2016 Jan; 57(1):109-19. Oni-Orisan A, Edin ML, Lee JA, Wells MA, Christensen ES, Vendrov KC, Lih FB, Tomer KB, Bai X, Taylor JM, Stouffer GA, Zeldin DC, Lee CR. PMID: 26555503.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    17. Pharmacogenomics in heart failure: where are we now and how can we reach clinical application? Cardiol Rev. 2014 Sep-Oct; 22(5):193-8. Oni-Orisan A, Lanfear DE. PMID: 25093738.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Epoxyeicosatrienoic acids and cardioprotection: the road to translation. J Mol Cell Cardiol. 2014 Sep; 74:199-208. Oni-Orisan A, Alsaleh N, Lee CR, Seubert JM. PMID: 24893205.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    19. Acute decompensated heart failure: evolving literature and implications for future practice. Pharmacotherapy. 2014; 34(4):373-88. Cicci JD, Reed BN, McNeely EB, Oni-Orisan A, Patterson JH, Rodgers JE. PMID: 24214219.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    20. Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug; 104-105:67-73. Oni-Orisan A, Deng Y, Schuck RN, Theken KN, Edin ML, Lih FB, Molnar K, DeGraff L, Tomer KB, Zeldin DC, Lee CR. PMID: 23000418.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    21. Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism. Am J Physiol Endocrinol Metab. 2012 Mar 01; 302(5):E500-9. Theken KN, Deng Y, Schuck RN, Oni-Orisan A, Miller TM, Kannon MA, Poloyac SM, Lee CR. PMID: 22185841.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals